{"id":"https://openalex.org/W2095162152","doi":"https://doi.org/10.1176/appi.ajp.162.2.386","title":"Improved P50 Auditory Gating With Ondansetron in Medicated Schizophrenia Patients","display_name":"Improved P50 Auditory Gating With Ondansetron in Medicated Schizophrenia Patients","alternate_titles":[],"publication_year":2005,"publication_date":"2005-01-27","ids":{"openalex":"https://openalex.org/W2095162152","doi":"https://doi.org/10.1176/appi.ajp.162.2.386","mag":"2095162152","pmid":"https://pubmed.ncbi.nlm.nih.gov/15677607"},"language":"en","primary_location":{"id":"doi:10.1176/appi.ajp.162.2.386","doi":"https://doi.org/10.1176/appi.ajp.162.2.386","is_oa":false,"landing_page_url":"https://doi.org/10.1176/appi.ajp.162.2.386","pdf_url":null,"source":{"id":"https://openalex.org/S116025658","display_name":"American Journal of Psychiatry","issn_l":"0002-953X","issn":["0002-953X","1535-7228"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","erih-plus","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310316602","host_organization_name":"American Psychiatric Association","host_organization_lineage":["https://openalex.org/P4310316602"],"host_organization_lineage_names":["American Psychiatric Association"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"American Journal of Psychiatry","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2095162152"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5111955519","display_name":"Lawrence E. Adler","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210101549","display_name":"Denver VA Medical Center","ror":"https://ror.org/018hk2b97","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1322918889","https://openalex.org/I2799886695","https://openalex.org/I4210101549","https://openalex.org/I4210113540","https://openalex.org/I4210148403"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Lawrence E. Adler","raw_affiliation_strings":["Denver VA Medical Center, 1055 Clermont St., Denver, CO 80220, USA. Lawrence.Adler@med.va.gov"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Denver VA Medical Center, 1055 Clermont St., Denver, CO 80220, USA. Lawrence.Adler@med.va.gov","institution_ids":["https://openalex.org/I4210101549"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5070416592","display_name":"Ellen M. Cawthra","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Ellen M. Cawthra","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5055266903","display_name":"Kara A. Donovan","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Kara A. Donovan","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111900611","display_name":"Josette G. Harris","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Josette G. Harris","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5055310312","display_name":"Herbert T. Nagamoto","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Herbert T. Nagamoto","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5027460018","display_name":"Ann Olincy","orcid":"https://orcid.org/0000-0001-6670-6549","observed_orcids":["https://orcid.org/0000-0001-6670-6549"]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Ann Olincy","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5109077677","display_name":"Merilyne C. Waldo","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Merilyne C. Waldo","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":4.4805,"has_fulltext":false,"cited_by_count":92,"citation_normalized_percentile":{"value":0.94622315,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":87,"max":98},"biblio":{"volume":"162","issue":"2","first_page":"386","last_page":"388"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10023","display_name":"Schizophrenia research and treatment","score":0.9955999851226807,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10023","display_name":"Schizophrenia research and treatment","score":0.9955999851226807,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11818","display_name":"Nicotinic Acetylcholine Receptors Study","score":0.0017999999690800905,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10056","display_name":"Neurotransmitter Receptor Influence on Behavior","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/ondansetron","display_name":"ondansetron","score":0.9319999814033508},{"id":"https://openalex.org/keywords/schizophrenia","display_name":"schizophrenia","score":0.6809999942779541},{"id":"https://openalex.org/keywords/auditory-sensory-gating","display_name":"auditory gating","score":0.7570000290870667},{"id":"https://openalex.org/keywords/5-ht3-receptor-antagonists","display_name":"5-HT3 receptor antagonists","score":0.843999981880188},{"id":"https://openalex.org/keywords/typical-antipsychotics","display_name":"typical antipsychotics","score":0.8349999785423279},{"id":"https://openalex.org/keywords/antipsychotic-treatment-response","display_name":"antipsychotic treatment response","score":0.47200000286102295}],"concepts":[{"id":"https://openalex.org/C2777170512","wikidata":"https://www.wikidata.org/wiki/Q410011","display_name":"Ondansetron","level":3,"score":0.9704403877258301},{"id":"https://openalex.org/C2779705967","wikidata":"https://www.wikidata.org/wiki/Q2271368","display_name":"Sensory gating","level":3,"score":0.6477272510528564},{"id":"https://openalex.org/C42219234","wikidata":"https://www.wikidata.org/wiki/Q131130","display_name":"Anesthesia","level":1,"score":0.628746509552002},{"id":"https://openalex.org/C27081682","wikidata":"https://www.wikidata.org/wiki/Q269829","display_name":"Placebo","level":3,"score":0.5892788171768188},{"id":"https://openalex.org/C2776412080","wikidata":"https://www.wikidata.org/wiki/Q7431605","display_name":"Schizophrenia (object-oriented programming)","level":2,"score":0.5432523488998413},{"id":"https://openalex.org/C15744967","wikidata":"https://www.wikidata.org/wiki/Q9418","display_name":"Psychology","level":0,"score":0.5111246705055237},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.47729527950286865},{"id":"https://openalex.org/C2780211496","wikidata":"https://www.wikidata.org/wiki/Q411188","display_name":"Aripiprazole","level":3,"score":0.4589042067527771},{"id":"https://openalex.org/C194544171","wikidata":"https://www.wikidata.org/wiki/Q21105679","display_name":"Gating","level":2,"score":0.3642646074295044},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.18222278356552124},{"id":"https://openalex.org/C169760540","wikidata":"https://www.wikidata.org/wiki/Q207011","display_name":"Neuroscience","level":1,"score":0.10489463806152344},{"id":"https://openalex.org/C2780852908","wikidata":"https://www.wikidata.org/wiki/Q127076","display_name":"Vomiting","level":2,"score":0.07053202390670776},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.0},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000161","descriptor_name":"Acoustic Stimulation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004311","descriptor_name":"Double-Blind Method","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004359","descriptor_name":"Drug Therapy, Combination","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005072","descriptor_name":"Evoked Potentials, Auditory","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010919","descriptor_name":"Placebos","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011978","descriptor_name":"Receptors, Nicotinic","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D012559","descriptor_name":"Schizophrenia","qualifier_ui":"Q000175","qualifier_name":"diagnosis","is_major_topic":false},{"descriptor_ui":"D012559","descriptor_name":"Schizophrenia","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D012702","descriptor_name":"Serotonin Antagonists","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D012702","descriptor_name":"Serotonin Antagonists","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D014150","descriptor_name":"Antipsychotic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017294","descriptor_name":"Ondansetron","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D017294","descriptor_name":"Ondansetron","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D018592","descriptor_name":"Cross-Over Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1176/appi.ajp.162.2.386","doi":"https://doi.org/10.1176/appi.ajp.162.2.386","is_oa":false,"landing_page_url":"https://doi.org/10.1176/appi.ajp.162.2.386","pdf_url":null,"source":{"id":"https://openalex.org/S116025658","display_name":"American Journal of Psychiatry","issn_l":"0002-953X","issn":["0002-953X","1535-7228"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","erih-plus","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310316602","host_organization_name":"American Psychiatric Association","host_organization_lineage":["https://openalex.org/P4310316602"],"host_organization_lineage_names":["American Psychiatric Association"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"American Journal of Psychiatry","raw_type":"journal-article"},{"id":"pmid:15677607","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/15677607","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The American journal of psychiatry","raw_type":"Clinical Trial"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.9537000060081482}],"study_designs":[],"awards":[{"id":"https://openalex.org/G2153731927","display_name":"ATYPICAL ANTIPSYCHOTICS AND P50 GATING IN SCHIZOPHRENIA","funder_award_id":"K02MH001121","funder_id":"https://openalex.org/F4320337346","funder_display_name":"National Institute of Mental Health"},{"id":"https://openalex.org/G7172585375","display_name":"Atypical Antipsychotics and P50 Sensory Gating","funder_award_id":"R01MH050787","funder_id":"https://openalex.org/F4320337346","funder_display_name":"National Institute of Mental Health"}],"funders":[{"id":"https://openalex.org/F4320337346","display_name":"National Institute of Mental Health","ror":"https://ror.org/04xeg9z08"}],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":11,"referenced_works":["https://openalex.org/W1532317254","https://openalex.org/W1643478577","https://openalex.org/W1996669209","https://openalex.org/W2024744942","https://openalex.org/W2027150892","https://openalex.org/W2063778638","https://openalex.org/W2085259372","https://openalex.org/W2128638450","https://openalex.org/W2140606211","https://openalex.org/W2222602361","https://openalex.org/W2419383765"],"related_works":["https://openalex.org/W2021839901","https://openalex.org/W2392244457","https://openalex.org/W4206736629","https://openalex.org/W2043674960","https://openalex.org/W2027176128","https://openalex.org/W2128638450","https://openalex.org/W2155381037","https://openalex.org/W1968830274","https://openalex.org/W2077106296","https://openalex.org/W2391289658"],"abstract_inverted_index":{"OBJECTIVE:":[0],"Most":[1],"schizophrenia":[2,52,120],"patients":[3,121],"have":[4],"a":[5,36,62,87],"deficit":[6],"in":[7,61,91,119],"auditory":[8,44,117],"sensory":[9],"gating,":[10],"which":[11],"appears":[12],"to":[13],"be":[14],"mediated":[15],"by":[16],"the":[17,32,42],"alpha-7":[18],"nicotinic":[19],"receptor,":[20],"that":[21],"is":[22],"not":[23],"improved":[24],"with":[25,51,123],"conventional":[26],"antipsychotic":[27],"treatment.":[28,96],"This":[29],"study":[30],"examined":[31],"effects":[33],"of":[34,82],"ondansetron,":[35],"highly":[37,88],"selective":[38],"5-HT3":[39],"antagonist,":[40],"on":[41],"P50":[43,92,116],"evoked":[45],"potential.":[46],"METHOD:":[47],"Eight":[48],"medicated":[49],"outpatients":[50],"were":[53,68],"given":[54],"either":[55],"ondansetron":[56,95],"(16":[57],"mg)":[58],"or":[59],"placebo":[60],"double-blind,":[63],"placebo-controlled":[64],"design.":[65],"Evoked":[66],"potentials":[67],"recorded":[69],"at":[70,102],"baseline":[71],"and":[72,77],"1":[73],"hour,":[74],"2":[75,103],"hours,":[76],"3":[78],"hours":[79,104],"after":[80,94],"receipt":[81],"drug.":[83],"RESULTS:":[84],"There":[85],"was":[86,101],"significant":[89],"improvement":[90],"gating":[93,118],"The":[97],"maximal":[98],"treatment":[99],"difference":[100],"posttreatment":[105],"(ondansetron:":[106],"mean=41.4%,":[107],"SD=39.7%;":[108],"placebo:":[109],"mean=80.2%,":[110],"SD=21.3%).":[111],"CONCLUSIONS:":[112],"Ondansetron":[113],"significantly":[114],"enhanced":[115],"treated":[122],"typical":[124],"antipsychotics.":[125]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2095162152","counts_by_year":[{"year":2026,"cited_by_count":2},{"year":2023,"cited_by_count":3},{"year":2022,"cited_by_count":1},{"year":2021,"cited_by_count":1},{"year":2020,"cited_by_count":3},{"year":2019,"cited_by_count":5},{"year":2018,"cited_by_count":3},{"year":2017,"cited_by_count":3},{"year":2015,"cited_by_count":2},{"year":2014,"cited_by_count":6},{"year":2013,"cited_by_count":5},{"year":2012,"cited_by_count":8}],"updated_date":"2026-11-21T10:27:49.728292","created_date":"2016-06-24T00:00:00"}
